This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne

Sponsored by Galderma Laboratorium GmbH

About this trial

Last updated 9 years ago

Study ID

PUMP-it

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
9+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 10 years ago

What is this trial about?

The purpose of this observational trial is to assess application and convenience of Epiduo® PUMP under daily clinical practice conditions in patients with moderate to severe inflammatory acne.

What are the participation requirements?

Yes

Inclusion Criteria

- Age ≥9 years

- The patient has been diagnosed with moderate to severe inflammatory acne (Leeds Grade 4-12)

- Chest/back affected allowed, but not required

- Topical therapy of acne with Epiduo® is indicated, the decision about treating the patient with Epiduo® has been made independently from this study

No

Exclusion Criteria

- Pregnancy or breastfeeding

- Acne inversa

- Acne with preferential manisfestation of microcysts, macrocysts and macrocomedones

- Hypersensitivity to the medication or any of the ingredients

- Other contraindications mentioned in the Epiduo® SPC